** Shares of Rua Life Sciences Plc RUA.L rise as much as
3.8% to 41.5p
** The holding company of a group of medical device
businesses forecasts a 34% jump in annual revenue, helped by
strength in its contract manufacture and biomaterials business
segments
** Co sees loss before tax for the year ended March 31 to be
similar to last year at around 2.3 mln pounds-2.4 mln pounds
($2.9 mln-$3 mln)
** RUA says further development and regulatory progress made
in vascular and structural heart segments
** Stock currently at session high, down about 15% YTD
($1 = 0.8061 pounds)
(Reporting by Aby Jose Koilparambil in Bengaluru)
((abyjose.koilparambil@thomsonreuters.com))